A survey of current evaluation and treatment of gout

Journal of Rheumatology

Volumn 33, Issue 10, 2006, Pages 2050-2052

  Schlesinger, Naomi ^a,d   Moore, Dirk F ^a   Sun, Jennifer D ^a   Schumacher Jr , H Ralph ^b,c  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Gout; Survey; Treatment

Indexed keywords

ALLOPURINOL; ANTIGOUT AGENT; COLCHICINE; CORTICOSTEROID; CORTICOTROPIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TRIAMCINOLONE; UNCLASSIFIED DRUG; URATE LOWERING AGENT; XANTHINE OXIDASE INHIBITOR;

CLINICAL PRACTICE; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; DRUG INDICATION; EVALUATION; GOUT; HEALTH SURVEY; HUMAN; HYPERURICEMIA; MEDICAL SPECIALIST; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RHEUMATOLOGY; URIC ACID BLOOD LEVEL;

ADRENAL CORTEX HORMONES; ADRENOCORTICOTROPIC HORMONE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLCHICINE; DRUG THERAPY, COMBINATION; GOUT; HEALTH CARE SURVEYS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; RHEUMATOLOGY; UNITED STATES; URIC ACID; URICOSURIC AGENTS;

EID: 33750034285     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Schlesinger N, Schumacher HR. Gout: How much of what we do is, evidence based? In: Tugwell P, Shea B, editors. Evidence-based rheumatology. London: BMJ Books; 2003:65-95.
2. Schlesinger N. Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs 2004;64:2399-416.
3. McCarty DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med 1961;54:452-60.
4. Rozenberg S, Lang T, Laatar A, Koeger AC, Orcel P, Bourgerois P. Diversity of opinions on the management of gout in France. A survey of 750 rheumatologists. Rev Rhum Engl Ed 1996;63:255-61.
5. Bellamy N, Gilbert JR, Brooks PM, Emmerson BT, Campbell J. A survey of current prescribing practices of anti-inflammatory and urate lowering drugs in gouty arthritis in the Province of Ontario. J Rheumatol 1988;15:1841-7.
6. Bellamy N, Brooks PM, Gilbert RJ, Campbell J, McCredie MA. Survey of current prescribing practices of anti-inflammatory and unite lowering drugs in gouty arthritis in New South Wales and Queensland. Med J Aust 1989;151:537-51.
7. Stuart RA, Gow PJ, Bellamy N, Campbell J, Grigor R. A survey of current prescribing practices of anti-inflammatory and urate-lowering drugs in gouty arthritis. NZ Med J 1991;104:115-7.
8. Wallace SL, Singer JZ. Review: systemic toxicity associated with the intravenous administration of colchicine - guidelines for use. J Rheumatol 1988;15:495-9.
9. Evans TI, Wheeler MT, Small RE, Breitbach SA, Sanders KM, Roberts WN. A comprehensive investigation of inpatient intravenous colchicine use shows more education is needed. J Rheumatol 1996;23:143-8.
10. Roberts WN, Liang MH, Stern SH. Colchicine in acute gout. Reassessment of risks and benefits. JAMA 1987;257:1920-2.
11. Fam AG. Should patients with interval gout be treated with urate lowering drugs? [editorial]. J Rheumatol 1995;22:1621-3.
12. Emmerson BT. The management of gout. N Engl J Med 1996;334:445-51.
13. Perez-Ruiz F, Calabozo M, Erauskin GG, Ruibal A, Herrero-Beites AM. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum 2002;47:610-3.
14. Pawlotsky Y. What is the optimal treatment for acute crystal induced arthritis? Rev Rheum Engl Ed 1996;63:231-3.
15. Perez-Ruiz F, Culabozo M, Pijoan SI, Herrero-Beites AM, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Care Res 2002; 47:356-60.
16. Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004;51:321-5.
17. Li-Yu J, Clayburnc G, Sieck M, et al. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001;28:577-80.
18. Kot TV, Day RO, Brooks PM. Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs? Med J Aust 1993;159:182-4.
19. Borstad GC, Bryant LR, Abel MP, Scroggie DA, Harris MD, Alloway JA. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol 2004;31:2429-32.